Development of efficacious combination therapies with RNA Polymerase I inhibitors
This study aims to develop effective combination therapies using RNA Polymerase I (Pol I) inhibitors to enhance therapeutic efficacy and combat resistance in cancer treatment through synergistic effects with other drugs or treatments.
Student intake
This project is open for Honours, Masters and PhD students.
Group
Research theme
Research themes
Project status
Project status
Potential
Contact
Contact
Content navigation
About
This study focuses on developing effective combination therapies involving RNA Polymerase I (Pol I) inhibitors. By exploring synergistic effects with other drugs or treatments, the research aims to enhance therapeutic efficacy and potentially overcome resistance in cancer treatment.